| Name | Title | Contact Details |
|---|
Gullapalli and Associates is a Jersey City, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Samaritan Health Services is a non-profit network of hospitals,physician clinics and health services caring for the communities of the mid-Willamette Valley and central Oregon Coast. Our passion is providing world-class health care to our friends and neighbors. On the job and off, each of us brings the caring and personal commitment to enhance the health of the region we call home. We provide innovative medicine and world-class quality in a way that`s consistent with the values of the places we serve. That includes care and compassion for everyone, regardless of the ability to pay.
Cleo is the support system for working families. With its integrated family benefits platform, Cleo combines proactive, expert guidance with an intuitive engagement hub to help connect families with the support they need to be their best at home and at work.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
For over 40 years, Global Health Labs has been a leading innovator in the natural products industry with loyal clients in the US and around the world.